scispace - formally typeset
A

Aminah Jatoi

Researcher at Mayo Clinic

Publications -  440
Citations -  15796

Aminah Jatoi is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 46, co-authored 404 publications receiving 12708 citations. Previous affiliations of Aminah Jatoi include University of Texas Health Science Center at San Antonio & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Healthcare Providers’ Experiences with Hiccups in Patients with Cancer: Report of a United States National Survey

TL;DR: Discordance appears to exist between the percentage of cancer patients with hiccups and the Percentage of cancer healthcare providers with awareness of their patients' hicc ups, Nonetheless, healthcare providers described notable hiccup-associated symptoms in their patients and a need for more palliative options.
Journal ArticleDOI

Developing & integrating a mobile application tool into a survivorship clinic for esophageal cancer patients

TL;DR: The Upper Digestive Disease Assessment (UDD) App as discussed by the authors is a mobile application designed to monitor symptom burden, direct assessment, and quantify data for patient outcome analysis after foregut (upper digestive) surgery, including esophagectomy.
Journal ArticleDOI

Should Vital Signs be Routinely Obtained Prior to Intravenous Chemotherapy? Results from a 2-Center Study:

TL;DR: There is a need for additional, evidence-based data to support the routine checking of vital signs prior to administering cancer chemotherapy, as shown in this trial.
Journal ArticleDOI

Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis

TL;DR: In this article , a retrospective analysis of patients with a history of early-onset colorectal cancer referred for genetic counseling at Mayo Clinic Rochester between April 2019 and April 2022 showed that only 84 patients (68%) with eoCRC completed genetic testing, with an average of 48 genes evaluated.